Patent details
EP3813882 Title: PHARMACEUTICAL COMBINATION COMPRISING A BIGUANID AND AN ACETYLCHOLINESTERASE INHIBITOR FOR USE IN AGE-RELATED AND/OR DEGENERATIVE DISEASES
Basic Information
- Publication number:
- EP3813882
- PCT Application Number:
- EP2019067645
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP197344013
- PCT Publication Number:
- WO2020002715
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMBINATION COMPRISING A BIGUANID AND AN ACETYLCHOLINESTERASE INHIBITOR FOR USE IN AGE-RELATED AND/OR DEGENERATIVE DISEASES
- French Title of Invention:
- COMBINAISON PHARMACEUTIQUE COMPRENANT UN BIGUANIDE ET UN INHIBITEUR DE LA CHOLINESTÉRASE POUR UTILISATION DANS LES MALADIES LIÉES À L'ÂGE
- German Title of Invention:
- PHARMAZEUTISCHE KOMBINATION MIT BIGUANID UND EINEM ACETYLCHOLINESTERASEHEMMER ZUR VERWENDUNG BEI ALTERSBEDINGTEN ERKRANKUNGEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 11/09/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 02/10/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 09/08/2023
- Unitary Effect Registration Date:
- 02/10/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 01/07/2019
- Grant date:
- 09/08/2023
- EP Publication Date:
- 05/05/2021
- PCT Publication Date:
- 02/01/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/08/2023
- EP B1 Publication Date:
- 09/08/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 01/07/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/08/2023
- Name:
- Rejuvenate Biomed
- Address:
- Wetenschapspark 13, 3590 Diepenbeek, Belgium (BE)
Inventor
- Name:
- BELIËN, Ann
- Address:
- Belgium (BE)
Priority
- Priority Number:
- 18180906
- Priority Date:
- 29/06/2018
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 31/13; A61K 45/06; A61K 31/155; A61K 31/445; A61K 31/55; A61K 31/27; A61P 3/00; A61P 21/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202332
- Publication date:
- 09/08/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202342
- Publication date:
- 18/10/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202344
- Publication date:
- 01/11/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|